Mecwins installs state-of-the-art AVAC platform at Destina Genomica
Advancing the fight against Alzheimer's disease (CPP2021-008902, ALZHEIMER-PROmiR-SENSOR) From [...]
Mecwins receives new patent in USA and EU
Mecwins announced today that a new method for [...]
New US patent granted to Mecwins
Mecwins announced today that a new patent has [...]
Mecwins has been granted with more than 1.3M€ in financial aid under the Colaboración Público Privada Program
Mecwins, in collaboration with Destina Genómica SL, with [...]
Monserrat Calleja, Winner of The Jaume I Award in the New Technologies 2022
Montserrat Calleja receiving the award [...]
Montserrat Calleja Gómez, co-founder of Mecwins SA, receives the Rei Jaume I Award of New Technology
Montserrat Calleja Gómez has been recognized for her [...]
Jesús Javier Cía Barrio, chosen as one of the best lawyers in Spain
Three lawyers from Pamplona selected as the top three [...]
Mecwins has been granted with more than 1.4M€ to develop ultrasensitive optoplasmonic immunoassays for the early detection of breast cancer under the Líneas Estratégicas Program
Mecwins, in collaboration with the Bionanomechanics Lab from [...]
Developing ‘Highly Sensitive’ Plasmonic Testing Tech
Mecwins Developing 'Highly Sensitive' Plasmonic Testing Tech for Laboratories, Point [...]
